Loss of heterozygosity and nonsense mutation in Apc in azoxymethane-induced colonic tumours in Min mice

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2595-2599

  Møllersen, Linda ^a   Paulsen, Jan Erik ^a   Alexander, Jan ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

catenin; Adenomatous polyposis coli; Azoxymethane; LOH; Min mice

Indexed keywords

BETA CATENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; MALE; MOUSE; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ANIMALS; AZOXYMETHANE; BETA CATENIN; CARCINOGENS; COCARCINOGENESIS; CODON, NONSENSE; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; FEMALE; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED C57BL; TRANS-ACTIVATORS;

EID: 6444237027     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Moser AR, Pilot HC and Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324, 1990.
2. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA and Dove WF: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670, 1992.
3. Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P: Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050, 1995.
4. Wong NA and Pignatelli M: Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160: 389-401, 2002.
5. + in intestinal adenomas from Min mice. Cancer Res 54: 5947-5952, 1994.
6. Møllersen L, Vikse R, Andreassen Å, Steffensen I-L, Mikalsen A, Paulsen JE and Alexander J: Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice. Mutat Res 557: 29-40, 2004.
7. Paulsen JE, Steffensen I-L, Namork E, Eide TJ and Alexander J: Age-dependent susceptibility to azoxymethane-induced and spontaneous tumorigenesis in the Min/+ mouse. Anticancer Res 23: 259-265, 2003.
8. Suzui M, Okuno M, Tanaka T, Nakagama H and Moriwaki H: Enhanced colon carcinogenesis induced by azoxymethane in Min mice occurs via a mechanism independent of beta-catenin mutation. Cancer Lett 183: 31-41, 2002.
9. Pegg AE: Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest 2: 223-231, 1984.
10. Margison GP, Santibanez Koref MF and Povey AC: Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis 17: 483-487, 2002.
11. Ochiai M, Ubagai T, Kawamori T, Imai H, Sugimura T and Nakagama H: High susceptibility of Scid mice to colon carcinogenesis induced by azoxymethane indicates a possible caretaker role for DNA-dependent protein kinase. Carcinogenesis 22: 1551-1555, 2001.
12. Takahashi M, Fukuda K, Sugimura T and Wakabayashi K: Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 58: 42-46, 1998.
13. Takahashi M, Nakatsugi S, Sugimura T and Wakabayashi K: Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 21: 1117-1120, 2000.
14. Yamada Y, Oyama T, Hirose Y, Hara A, Sugie S, Yoshida K, Yoshimi N and Mori H: beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis 24: 91-97, 2003.
15. Paulsen JE, Steffensen I-L, Løberg EM, Husøy T, Namork E and Alexander J: qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse Colon. Cancer Res 61: 5010-5015, 2001.
16. Maltzman T, Whittington J, Driggers L, Stephens J and Ahnen, D: AOM-induced mouse colon tumors do not express full-length APC protein. Carcinogenesis 18: 2435-2439, 1997.
17. Steffensen I-L, Paulsen JE, Eide TJ and Alexander J: 2-Amino-1-methyl-6- phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis 18: 1049-1054, 1997.
18. Andreassen Å, Vikse R, Steffensen I-L, Paulsen JE and Alexander J: Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-o]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele. Mutagenesis 16: 309-315, 2001.
19. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B and Kinzler KW: Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54: 5953-5958, 1994.
20. Shoemaker AR, Luongo C, Moser AR, Marton LJ and Dove WF: Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res 57: 1999-2006, 1997.
21. Andreassen Å, Møllersen L, Vikse R, Steffensen I-L, Mikalsen A, Paulsen JE and Alexander J: One dose of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) or 2-amino-3-methylimidazo [4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Ape gene. Mutat Res 517: 157-166, 2002.
22. Sommer SS: PCR amplification of specific alleles. Science 255: 514, 1992.
23. Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli NC and Lander ES: A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131: 423-447, 1992.
24. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790, 1997.
25. Bjerknes M and Cheng H: Colossal crypts bordering colon adenomas in Apc(Min) mice express full-length Apc. Am J Pathol 154: 1831-1834, 1999.
26. De Filippo C, Caderni G, Bazzicalupo M, Briani C, Giannini A, Fazi M and Dolara P: Mutations of the Ape gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br J Cancer 77: 2148-2151, 1998.
27. Nagaoka H, Wakabayashi K, Kim SB, Kim IS, Tanaka Y, Ochiai M, Tada A, Nukaya H, Sugimura T and Nagao M: Adduct formation at C-8 of guanine on in vitro reaction of the ultimate form of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine with 2′-deoxyguanosine and its phosphate esters. Jpn J Cancer Res 83: 1025-1029, 1992.
28. Haigis KM, Caya JG, Reichelderfer M and Dove WF: Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci USA 99: 8927-8931, 2002.
29. Wijnhoven SW, Sonneveld E, Kool HJ, van Teijlingen CM and Vrieling H: Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes. Carcinogenesis 24: 139-144, 2003.